×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| INVESCO India Gold Exchange Tr | NA | NA | NA | NA | 0 | |
| MOTILAL OSWAL MOST SHARES NASD | NA | NA | NA | NA | 0 | |
| Emcure Pharmaceuticals Limited | 11180.97 | 1227.89 | 10965.73 | 6.48 | 24,337 | 32.3 |
| Aadhar Housing Finance Limited | 8513.4 | 2372.8 | 8481.8 | 5.37 | 22168 | 23.4 |
| Brookfield India Real Estate T | NA | NA | NA | NA | 21824 | 85.3 |
Emcure Pharmaceuticals Limited has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Sales | 970.3 | 1,104.6 | 1,028.8 | 1,278.2 | 1,096.6 |
| Expenses | 855.1 | 952.5 | 904.4 | 1,033.5 | 868.6 |
| Operating Profit | 115.2 | 152.2 | 124.4 | 244.7 | 228.0 |
| OPM % | 11.87% | 13.77% | 12.09% | 19.14% | 20.79% |
| Other Income | 32.5 | 54.9 | 19.4 | 22.4 | 18.0 |
| Interest | 37.6 | 31.4 | 19.9 | 24.1 | 20.5 |
| Depreciation | 55.1 | 56.3 | 56.6 | 56.9 | 59.8 |
| Profit before tax | 55.0 | 119.4 | 67.3 | 186.1 | 169.2 |
| Tax % | 26.5% | -27.2% | -25.3% | -24.9% | 25.9% |
| Net Profit | 40.4 | 86.9 | 50.2 | 139.6 | 122.8 |
| EPS in Rs | 2.23 | 4.62 | 2.65 | 0 | 6.48 |
| Metrics | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 1,815.1 | 2,002.0 | 1,962.6 | 2,116.2 |
| Expenses | 1,478.8 | 1,621.1 | 1,608.0 | 1,713.8 |
| Operating Profit | 336.3 | 380.9 | 354.6 | 402.4 |
| OPM % | 18.53% | 19.02% | 18.07% | 19.02% |
| Other Income | 23.4 | 35.7 | 3.9 | -5.9 |
| Interest | 58.8 | 46.2 | 31.8 | 39.0 |
| Depreciation | 93.6 | 96.9 | 96.8 | 96.8 |
| Profit before tax | 207.4 | 273.4 | 229.9 | 271.0 |
| Tax % | -26.4% | 26.3% | 32.1% | -24.3% |
| Net Profit | 152.6 | 201.5 | 156.1 | 197.2 |
| EPS in Rs | 7.95 | 10.33 | 8.12 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 13% |
| 3 Years: | 9% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | -11% |
| TTM: | 95% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 36% |
| 3 Years: | 1% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|